Robbyn E Sockolow, MD Associate Professor of Clinical Pediatrics Director of Pediatric...
-
Upload
egbert-hoover -
Category
Documents
-
view
220 -
download
2
Transcript of Robbyn E Sockolow, MD Associate Professor of Clinical Pediatrics Director of Pediatric...
![Page 1: Robbyn E Sockolow, MD Associate Professor of Clinical Pediatrics Director of Pediatric Gastroenterology New York Presbyterian- Weill Cornell Medical Center.](https://reader036.fdocuments.in/reader036/viewer/2022062407/56649d0b5503460f949de093/html5/thumbnails/1.jpg)
Robbyn E Sockolow, MD
Associate Professor of Clinical Pediatrics
Director of Pediatric Gastroenterology
New York Presbyterian- Weill Cornell Medical Center
Taking Care of the Whole Child
![Page 2: Robbyn E Sockolow, MD Associate Professor of Clinical Pediatrics Director of Pediatric Gastroenterology New York Presbyterian- Weill Cornell Medical Center.](https://reader036.fdocuments.in/reader036/viewer/2022062407/56649d0b5503460f949de093/html5/thumbnails/2.jpg)
HEALTH SUPERVISION: OUTLINE
• Growth and nutrition
• Disease activity
• Prevention and surveillance
• Psychosocial well being
![Page 3: Robbyn E Sockolow, MD Associate Professor of Clinical Pediatrics Director of Pediatric Gastroenterology New York Presbyterian- Weill Cornell Medical Center.](https://reader036.fdocuments.in/reader036/viewer/2022062407/56649d0b5503460f949de093/html5/thumbnails/3.jpg)
HEALTH SUPERVISION: OUTLINE• Growth and nutrition
• Height, Weight, BMI, Bone Health• Disease activity
• Mission = Remission• Prevention and surveillance
• Vaccinations
• Cancer screening• Psychosocial well being
• Screening for anxiety/depression
![Page 4: Robbyn E Sockolow, MD Associate Professor of Clinical Pediatrics Director of Pediatric Gastroenterology New York Presbyterian- Weill Cornell Medical Center.](https://reader036.fdocuments.in/reader036/viewer/2022062407/56649d0b5503460f949de093/html5/thumbnails/4.jpg)
AREAS OF SUPERVISION
• Vaccination Status
• Vitamin Status
• Bone Health
• Ophthalmologic health
• Dermatologic health
• Annual PPD
![Page 5: Robbyn E Sockolow, MD Associate Professor of Clinical Pediatrics Director of Pediatric Gastroenterology New York Presbyterian- Weill Cornell Medical Center.](https://reader036.fdocuments.in/reader036/viewer/2022062407/56649d0b5503460f949de093/html5/thumbnails/5.jpg)
VACCINES
![Page 6: Robbyn E Sockolow, MD Associate Professor of Clinical Pediatrics Director of Pediatric Gastroenterology New York Presbyterian- Weill Cornell Medical Center.](https://reader036.fdocuments.in/reader036/viewer/2022062407/56649d0b5503460f949de093/html5/thumbnails/6.jpg)
IMMUNOSUPPRESSION:
• Treatment with glucocorticoids (prednisone 20 mg/d equivalent, or 2 mg/kg/d if less than 10 kg, for 2 weeks or more, and within 3 months of stopping).
• Treatment with effective doses of 6-mercaptopurine/azathioprine (effect on safety not established) and within 3 months of stopping.
• Treatment with methotrexate (effect on safety not established) and within 3 months of stopping.
• Treatment with infliximab/adalimumab (effect on safety not established) and within 3 months of stopping.
• Significant protein-calorie malnutrition.
SANDS ET AL INFLAMM BOWEL DIS 2004;10:677
![Page 7: Robbyn E Sockolow, MD Associate Professor of Clinical Pediatrics Director of Pediatric Gastroenterology New York Presbyterian- Weill Cornell Medical Center.](https://reader036.fdocuments.in/reader036/viewer/2022062407/56649d0b5503460f949de093/html5/thumbnails/7.jpg)
VACCINES THAT ARE KILLED AND CONSIDERED SAFE
• IM/SC influenza vaccine
• Hepatitis A and B vaccine
• Meningococcal vaccine
• Human Papilloma virus vaccine
• Pneumovax
![Page 8: Robbyn E Sockolow, MD Associate Professor of Clinical Pediatrics Director of Pediatric Gastroenterology New York Presbyterian- Weill Cornell Medical Center.](https://reader036.fdocuments.in/reader036/viewer/2022062407/56649d0b5503460f949de093/html5/thumbnails/8.jpg)
• Anthrax vaccine
• Intranasal influenza
• Measles-mumps-rubella (MMR)
• Polio live oral vaccine (OPV)
• Rotavirus (oral)
• Smallpox vaccine
• Tuberculosis BCG vaccine
• Typhoid live oral vaccine
• Varicella
• Yellow fever
LIVE VACCINES
![Page 9: Robbyn E Sockolow, MD Associate Professor of Clinical Pediatrics Director of Pediatric Gastroenterology New York Presbyterian- Weill Cornell Medical Center.](https://reader036.fdocuments.in/reader036/viewer/2022062407/56649d0b5503460f949de093/html5/thumbnails/9.jpg)
Proportion of subjects achieving a post-vaccination of Pneumococcal Polysaccharide Vaccine geometric mean titer (GMT) 1 μ g / 100
Melmed G et al. Am J Gastroenterol 2010; 105:148–154
![Page 10: Robbyn E Sockolow, MD Associate Professor of Clinical Pediatrics Director of Pediatric Gastroenterology New York Presbyterian- Weill Cornell Medical Center.](https://reader036.fdocuments.in/reader036/viewer/2022062407/56649d0b5503460f949de093/html5/thumbnails/10.jpg)
PEDIATRIC IBD: HEALTH SCREENING
• Confirm vaccine efficacy at diagnosis
• Maximizes time available to immunize
• Titers for Varicella, Hepatitis BsAb and Hepatitis A IgG, MMR??
• PPD at diagnosis
• Confirm before biologics
![Page 11: Robbyn E Sockolow, MD Associate Professor of Clinical Pediatrics Director of Pediatric Gastroenterology New York Presbyterian- Weill Cornell Medical Center.](https://reader036.fdocuments.in/reader036/viewer/2022062407/56649d0b5503460f949de093/html5/thumbnails/11.jpg)
VACCINES IN PEDIATRIC IBD:CONTINUE INACTIVATED VACCINATIONS
Inactivated vaccines—stay on schedule
• Tetanus, Diphtheria, Pertussis (DPT)
• Human Papilloma virus (HPV)
• Influenza (injectable only)
• Pneumococcal
• Hepatitis A and Hepatitis B
• Meningococcal
Melmed GY. Inflamm Bowel Dis 2009;15:1410–1416.Wasan SK et al., Clin Gastroenterol Hepatol 2010;8:1013–1016
![Page 12: Robbyn E Sockolow, MD Associate Professor of Clinical Pediatrics Director of Pediatric Gastroenterology New York Presbyterian- Weill Cornell Medical Center.](https://reader036.fdocuments.in/reader036/viewer/2022062407/56649d0b5503460f949de093/html5/thumbnails/12.jpg)
LIMIT LIVE/ATTENUATED VACCINATIONS
NO live or attenuated vaccines if taking IM/Biologics
• Measles mumps rubella (MMR) – wait 6 weeks
• Varicella (titer at diagnosis) – wait 4-12 weeks
• Intranasal influenza
• Oral polio
• Smallpox
• Yellow Fever
Melmed GY. Inflamm Bowel Dis 2009;15:1410–1416.Wasan SK et al., Clin Gastroenterol Hepatol 2010;8:1013–1016
![Page 13: Robbyn E Sockolow, MD Associate Professor of Clinical Pediatrics Director of Pediatric Gastroenterology New York Presbyterian- Weill Cornell Medical Center.](https://reader036.fdocuments.in/reader036/viewer/2022062407/56649d0b5503460f949de093/html5/thumbnails/13.jpg)
TRAVEL RELATED LIVE/ATTENUATED VACCINES
• Anthrax
• Bacillus Calmette Guérin (BCG)
• Smallpox
• Oral Typhoid
• Yellow Fever
![Page 14: Robbyn E Sockolow, MD Associate Professor of Clinical Pediatrics Director of Pediatric Gastroenterology New York Presbyterian- Weill Cornell Medical Center.](https://reader036.fdocuments.in/reader036/viewer/2022062407/56649d0b5503460f949de093/html5/thumbnails/14.jpg)
PEDIATRIC IBD: LIMITS ONLIVE/ATTENUATED VACCINATIONS
• Consider immunization before initiation of immunosuppressive therapy
• Consider checking post-vaccine titers
Melmed GY. Inflamm Bowel Dis 2009;15:1410–1416.Wasan SK et al., Clin Gastroenterol Hepatol 2010;8:1013–1016
![Page 15: Robbyn E Sockolow, MD Associate Professor of Clinical Pediatrics Director of Pediatric Gastroenterology New York Presbyterian- Weill Cornell Medical Center.](https://reader036.fdocuments.in/reader036/viewer/2022062407/56649d0b5503460f949de093/html5/thumbnails/15.jpg)
BONE HEALTH
![Page 16: Robbyn E Sockolow, MD Associate Professor of Clinical Pediatrics Director of Pediatric Gastroenterology New York Presbyterian- Weill Cornell Medical Center.](https://reader036.fdocuments.in/reader036/viewer/2022062407/56649d0b5503460f949de093/html5/thumbnails/16.jpg)
PEDIATRIC IBD: BONES AT RISK
• At risk for decreased bone mass
• Often present at diagnosis (disease related)
• Can be acquired over time (treatment related)
• Potential for increase in fracture risk
• Vertebral and long bone
Pappa H, et al. J Pediatr Gastroenterol Nutr 2011;53:11–25Sylvester FA, et al. Inflamm Bowel Dis 2007;13:42-50
![Page 17: Robbyn E Sockolow, MD Associate Professor of Clinical Pediatrics Director of Pediatric Gastroenterology New York Presbyterian- Weill Cornell Medical Center.](https://reader036.fdocuments.in/reader036/viewer/2022062407/56649d0b5503460f949de093/html5/thumbnails/17.jpg)
Vitamin D3 & Crohn’s Disease: Manitoba IBD Registry
Increased prevalence of vitamin D deficiency in Inflammatory bowel disease
Leslie WD, Miller N, Rogala L, Bernstein CN. Vitamin D status and bone density in recently diagnosed inflammatory bowel disease: the Manitoba IBD Cohort Study. AJG. 2008 Jun;103(6)
![Page 18: Robbyn E Sockolow, MD Associate Professor of Clinical Pediatrics Director of Pediatric Gastroenterology New York Presbyterian- Weill Cornell Medical Center.](https://reader036.fdocuments.in/reader036/viewer/2022062407/56649d0b5503460f949de093/html5/thumbnails/18.jpg)
NORMAL BONE VS OSTEOPOROTIC BONE
Loss of trabecular plates results in weakened bone structure significantly increasing risk of fractures.
75 yo normal woman 47 yo s/p multiple vertebral compression fractures
![Page 19: Robbyn E Sockolow, MD Associate Professor of Clinical Pediatrics Director of Pediatric Gastroenterology New York Presbyterian- Weill Cornell Medical Center.](https://reader036.fdocuments.in/reader036/viewer/2022062407/56649d0b5503460f949de093/html5/thumbnails/19.jpg)
DEXA SCREENING FOR BONE HEALTH:PEDIATRIC PEARLS
• Order total body (minus skull)• Need a pediatric experienced site!• Age and sex adjusted Z scores (not T-scores!)• Patient size affects the test—may have to adjust• Interpretation• Z-score < ‐2.0 = significant deficit• Z-score < -1.0 = monitor closely
Pappa H, et al. J Pediatr Gastroenterol Nutr 2011;53:11–25Lewiecki EM, et al. Bone 2008;43:1115-1121
![Page 20: Robbyn E Sockolow, MD Associate Professor of Clinical Pediatrics Director of Pediatric Gastroenterology New York Presbyterian- Weill Cornell Medical Center.](https://reader036.fdocuments.in/reader036/viewer/2022062407/56649d0b5503460f949de093/html5/thumbnails/20.jpg)
Fewtrell et al, Bone densitometry in children assessed by dual x ray absorptiometry: uses and pitfalls Arch Dis Child 2003: 88; 795-798
![Page 21: Robbyn E Sockolow, MD Associate Professor of Clinical Pediatrics Director of Pediatric Gastroenterology New York Presbyterian- Weill Cornell Medical Center.](https://reader036.fdocuments.in/reader036/viewer/2022062407/56649d0b5503460f949de093/html5/thumbnails/21.jpg)
PEDIATRIC IBD:WHEN TO OBTAIN DEXA
• Recommended at diagnosis
• Repeat “when clinically indicated”• Slowed growth velocity (height z-score <2)
• Previous BMD z-score < -1
• Delayed puberty or amenorrhea
• Severe course especially if low albumin
• Prolonged steroid use (> 6 months)
Pappa H, et al. J Pediatr Gastroenterol Nutr 2011;53:11–25
![Page 22: Robbyn E Sockolow, MD Associate Professor of Clinical Pediatrics Director of Pediatric Gastroenterology New York Presbyterian- Weill Cornell Medical Center.](https://reader036.fdocuments.in/reader036/viewer/2022062407/56649d0b5503460f949de093/html5/thumbnails/22.jpg)
BONE IN PEDIATRIC IBD: THERAPY
• Control inflammation
• Optimize nutrition
• Monitor growth and development (menses)
• Weight-bearing activity
• Optimize Vitamin D/calcium status
• Specialist if complication occurs • e.g. Compression fracture
Pappa H, et al. J Pediatr Gastroenterol Nutr 2011;53:11–25
![Page 23: Robbyn E Sockolow, MD Associate Professor of Clinical Pediatrics Director of Pediatric Gastroenterology New York Presbyterian- Weill Cornell Medical Center.](https://reader036.fdocuments.in/reader036/viewer/2022062407/56649d0b5503460f949de093/html5/thumbnails/23.jpg)
VITAMIN D IN PEDIATRIC IBD
• Deficiency in >30% of pediatric IBD patients
• Higher risk: Darker complexion, active disease
• Measure yearly 25-OH level: Later winter/spring
• Keep level > 32 ng/mL
• 800 to 1,000 IU/day as maintenance (D3)
• Supplement Calcium 1,000—1,600mg a day
Pappa H, et al. Pediatrics 2006;118:1950 -1961 Pappa H, et al. J Pediatr Gastroenterol Nutr 2011;53:11–25
![Page 24: Robbyn E Sockolow, MD Associate Professor of Clinical Pediatrics Director of Pediatric Gastroenterology New York Presbyterian- Weill Cornell Medical Center.](https://reader036.fdocuments.in/reader036/viewer/2022062407/56649d0b5503460f949de093/html5/thumbnails/24.jpg)
CANCER PREVENTION
![Page 25: Robbyn E Sockolow, MD Associate Professor of Clinical Pediatrics Director of Pediatric Gastroenterology New York Presbyterian- Weill Cornell Medical Center.](https://reader036.fdocuments.in/reader036/viewer/2022062407/56649d0b5503460f949de093/html5/thumbnails/25.jpg)
PEDIATRIC IBD: CANCER SCREENING
• Skin cancer
• 1o prevention (hats, sunglasses, SPF > 30)
• Yearly dermatologic screening
• Especially if using immunomodulators/Biologics
• Articles for both Thiopurines and Biologics in Rheum literature
Peyrin-Biroulet et al Gastro 2011 Cesame Group Nancy FranceLong MD, et al. Inflamm Bowel Dis 2011;17:1423-1427Rubenstein et al. Am J Gastroenterol 2009;104:2222-2232Kramagar et al J Dermat Treat UCSF 2012
![Page 26: Robbyn E Sockolow, MD Associate Professor of Clinical Pediatrics Director of Pediatric Gastroenterology New York Presbyterian- Weill Cornell Medical Center.](https://reader036.fdocuments.in/reader036/viewer/2022062407/56649d0b5503460f949de093/html5/thumbnails/26.jpg)
PEDIATRIC IBD: CANCER SCREENING
• Colonoscopy
• Screen 7-10 yrs if colonic disease diagnosed
• Yearly if diagnosed with PSC
• Surveillance every 1-2 subsequent years
• Pouchoscopy and cuff biopsies after IPAA
![Page 27: Robbyn E Sockolow, MD Associate Professor of Clinical Pediatrics Director of Pediatric Gastroenterology New York Presbyterian- Weill Cornell Medical Center.](https://reader036.fdocuments.in/reader036/viewer/2022062407/56649d0b5503460f949de093/html5/thumbnails/27.jpg)
MENTAL HEALTH
![Page 28: Robbyn E Sockolow, MD Associate Professor of Clinical Pediatrics Director of Pediatric Gastroenterology New York Presbyterian- Weill Cornell Medical Center.](https://reader036.fdocuments.in/reader036/viewer/2022062407/56649d0b5503460f949de093/html5/thumbnails/28.jpg)
ASSESSING PSYCHOSOCIAL WELLNESS
• Situational distress vs prolonged functional impairment
• 25% develop anxiety and/or depression
• Frequent follow up visits allow screening
• Adherence and psychosocial wellness
• Focus on the child/ adolescent
Mackner LM, et al. Inflamm Bowel Dis 2006;12:239-244 Engstrom I. J Child Psychol Psychiatry 1992;33:563-582 Szigethy E, et al. J Pediatr Gastroenterol Nutr 2004;39:395-403
![Page 29: Robbyn E Sockolow, MD Associate Professor of Clinical Pediatrics Director of Pediatric Gastroenterology New York Presbyterian- Weill Cornell Medical Center.](https://reader036.fdocuments.in/reader036/viewer/2022062407/56649d0b5503460f949de093/html5/thumbnails/29.jpg)
INTERVENTION:DEPRESSION/ANXIETY
• Appropriate referral to a mental health professional
• Cognitive behavioral therapy (CBT): best evidence for treating anxiety, depression
Szigethy E, et al. Child Adolesc Psychiatr Clin N Am 2010;19:301-318
![Page 30: Robbyn E Sockolow, MD Associate Professor of Clinical Pediatrics Director of Pediatric Gastroenterology New York Presbyterian- Weill Cornell Medical Center.](https://reader036.fdocuments.in/reader036/viewer/2022062407/56649d0b5503460f949de093/html5/thumbnails/30.jpg)
PSYCHOSOCIAL INTERVENTION: PEDIATRIC IBD
• Therapeutic relationship
• Support groups, CCFA camp
• ? Role of self-management programs
• ?Role of social networks/websites
Shepanski MA, et al. Inflamm Bowel Dis 2005;11:164–170Szigethy E, et al. Inflamm Bowel Dis 2009;15:1127-1128